info@ceoworld.biz
Thursday, October 10, 2024
CEOWORLD magazine - Latest - Money and Wealth - Sanofi CEO Paul Hudson’s salary takes another dip to €10.57 million

Money and Wealth

Sanofi CEO Paul Hudson’s salary takes another dip to €10.57 million

Sanofi

Sanofi CEO Paul Hudson’s compensation has slightly decreased for the third consecutive year. As per the company’s annual filing, he will receive €10.57 million in total pay for 2023, which is lower than his compensation of €10.72 million in 2022. In his first year as CEO of the Paris-based company, Hudson collected €11.34 million in 2020, while in 2021, his pay was €10.98 million.

  • Sanofi CEO Paul Hudson’s Pay in 2023: €10.57 million
  • Sanofi CEO Paul Hudson’s Pay in 2022: €10.72 million
  • Sanofi CEO Paul Hudson’s Pay in 2021: €10.98 million
  • Sanofi CEO Paul Hudson’s Pay in 2020: €11.34 million

CEOs of major European pharma companies typically are not compensated as well as their counterparts in the United States. AstraZeneca recently reported that Pascal Soriot collected £16.9 million (US$21.3 million) in 2023, while Novartis CEO Vas Narasimhan received 13.3 million Swiss francs (US$15.3 million) last year.

In the intricate financial landscape of 2023, the compensation trends of top executives have become a focal point for discussions around corporate governance and equity. A notable example is Sanofi’s CEO, Paul Hudson, whose pay package has seen a reduction for the third consecutive year. This development is not just a reflection of individual performance or corporate strategy, but it also sets a broader precedent in the pharmaceutical industry and beyond.

This trend of reducing CEO compensation, particularly in a high-stakes industry like pharmaceuticals, speaks volumes about the shifting dynamics of executive remuneration. Traditionally, CEO pay has been closely tied to company performance, often resulting in substantial bonuses and stock options for leading a company to financial success. However, Hudson’s decreasing compensation suggests a possible reevaluation of how success is measured and rewarded in the corporate world.

In a broader sense, Sanofi’s approach to executive compensation may encourage other corporations to reconsider their own policies, potentially leading to more balanced and fair compensation practices across industries. This could have significant impacts on corporate culture, employee morale, and public perception, contributing to a more equitable and responsible corporate landscape.


Have you read?
Revealed: These Are The Richest Countries In The World, 2024.
Revealed: Countries with Highest Gun Ownership, 2024.
Revealed: These Countries Pay Their Olympians For Winning Gold Medals, 2024.
Revealed: Happiest countries in the world for 2024.
Report: What Is the Most Common Hair Color in the World?


Add CEOWORLD magazine to your Google News feed.
Follow CEOWORLD magazine headlines on: Google News, LinkedIn, Twitter, and Facebook.
Copyright 2024 The CEOWORLD magazine. All rights reserved. This material (and any extract from it) must not be copied, redistributed or placed on any website, without CEOWORLD magazine' prior written consent. For media queries, please contact: info@ceoworld.biz
CEOWORLD magazine - Latest - Money and Wealth - Sanofi CEO Paul Hudson’s salary takes another dip to €10.57 million
Katherina Davis
Deputy News Editor at CEOWORLD Magazine. Covering money, work, and lifestyle stories. Covering issues of importance to public company nominating and corporate governance committees, including new director recruitment, board evaluations, onboarding, director compensation and overall corporate governance. More recently, I have joined the newsletters team, writing and editing some of the CEOWORLD Magazine's key reader emails.